Dr. Mhd Adnan Alsaka, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 101 S Ravenel St, Suite 120, Florence, SC 29506 Phone: 843-777-7290 Fax: 843-777-7280 |
Venugopal Govindappa, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 255 Warley St, Florence, SC 29501 Phone: 843-669-6694 Fax: 843-669-2500 |
Mr. Wen-ting Ouyang, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 255 Warley St, Florence, SC 29501 Phone: 843-669-6694 Fax: 843-669-2500 |
Mr. John Cameron Pittard, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 255 Warley St, Florence, SC 29501 Phone: 843-669-6694 Fax: 843-669-2500 |
Mr. Inderpal Singh, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 255 Warley St, Florence, SC 29501 Phone: 843-669-6694 Fax: 843-669-2500 |
Dr. Sompong Kraikit, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1120 Dunvegan Rd, Florence, SC 29501 Phone: 843-665-6909 |
News Archive
The fact is that Republicans and (Grover) Norquist both face a new political reality on taxes. President Obama's re-election means that taxes for upper-income earners are going up one way or another. The Bush rates expire on December 31 unless Mr. Obama signs an extension, and he shows no inclination to do so. ... This is where Mr. Norquist can give some ground.
We classified ‘long-term' cannabis use as being regular, at least weekly, cannabis use for over 12 months. This is the period of time that's used in the DSM-IV psychiatric diagnostic manual to classify substance use disorders. In our study the average duration of at least weekly use was just over four and a half years.
Gaucher disease, a rare enzyme deficiency disorder, is one of many conditions with few approved treatment options for patients. In a study published online today in Blood, the journal of the American Society of Hematology, researchers present positive results of a Phase II clinical trial of eliglustat tartrate, an oral therapy in development to treat Gaucher disease.
Ground-breaking research conducted by research experts with AbScent's Long Covid online group has recorded for the first time the wider impact of altered sensing on people's daily lives.
› Verified 2 days ago